DE69131624T2 - Peptidzusammensetzung aus pseudomonas und methode diese herzustellen - Google Patents

Peptidzusammensetzung aus pseudomonas und methode diese herzustellen

Info

Publication number
DE69131624T2
DE69131624T2 DE69131624T DE69131624T DE69131624T2 DE 69131624 T2 DE69131624 T2 DE 69131624T2 DE 69131624 T DE69131624 T DE 69131624T DE 69131624 T DE69131624 T DE 69131624T DE 69131624 T2 DE69131624 T2 DE 69131624T2
Authority
DE
Germany
Prior art keywords
peptide
reactive
cross
pseudomonas
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131624T
Other languages
English (en)
Other versions
DE69131624D1 (de
Inventor
Robert Hodges
William Paranchych
Randall Irvin
Kok Lee
Sastry Parimi
Dick Zoutmon
Peter Doig
Wah Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SPI Synthetic Peptides Inc
Original Assignee
SPI Synthetic Peptides Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPI Synthetic Peptides Inc filed Critical SPI Synthetic Peptides Inc
Application granted granted Critical
Publication of DE69131624D1 publication Critical patent/DE69131624D1/de
Publication of DE69131624T2 publication Critical patent/DE69131624T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69131624T 1991-01-04 1991-12-24 Peptidzusammensetzung aus pseudomonas und methode diese herzustellen Expired - Fee Related DE69131624T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/638,492 US5494672A (en) 1989-04-28 1991-01-04 Pseudomonas peptide composition and method
PCT/CA1991/000459 WO1992012169A1 (en) 1991-01-04 1991-12-24 Pseudomonas peptide composition and method for producing the same

Publications (2)

Publication Number Publication Date
DE69131624D1 DE69131624D1 (de) 1999-10-21
DE69131624T2 true DE69131624T2 (de) 2000-05-31

Family

ID=24560266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131624T Expired - Fee Related DE69131624T2 (de) 1991-01-04 1991-12-24 Peptidzusammensetzung aus pseudomonas und methode diese herzustellen

Country Status (8)

Country Link
US (1) US5494672A (de)
EP (1) EP0567470B1 (de)
JP (1) JPH06504528A (de)
AT (1) ATE184612T1 (de)
AU (1) AU661465B2 (de)
CA (1) CA2098296C (de)
DE (1) DE69131624T2 (de)
WO (1) WO1992012169A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
JPH0797395A (ja) * 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
EP1083922B1 (de) 1998-06-12 2003-04-09 The Governors Of The University Of Alberta Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen
US20030228324A1 (en) * 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
US7132101B2 (en) * 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
AU2005294436A1 (en) * 2004-10-04 2006-04-20 Trinity Biosystems, Inc. Methods and compositions for immunizing against Pseudomonas infection
EP1919494A4 (de) 2005-07-22 2011-11-09 Univ Colorado Regents Nichttoxischer biofolien-hemmer
BR112013016254A2 (pt) * 2010-12-23 2017-07-11 Intercell Austria Ag agentes oprf/i e seu uso em pacientes hospitalizados e outros
WO2012145758A1 (en) * 2011-04-22 2012-10-26 University Of Medicine And Dentistry Of New Jersey Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886663A (en) * 1983-01-03 1989-12-12 Scripps Clinic And Research Foundation Synthetic heat-stable enterotoxin polypeptide of Escherichia coli and multimers thereof
US4745055A (en) * 1985-05-07 1988-05-17 California Biotechnology Inc. Fused protein for enzyme immunoassay system
WO1988008430A1 (en) * 1987-04-27 1988-11-03 Commonwealth Scientific And Industrial Research Or Peptide production by protein engineering
CA1340530C (en) * 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method

Also Published As

Publication number Publication date
CA2098296C (en) 1998-08-04
AU661465B2 (en) 1995-07-27
AU9095991A (en) 1992-08-17
EP0567470A1 (de) 1993-11-03
JPH06504528A (ja) 1994-05-26
WO1992012169A1 (en) 1992-07-23
CA2098296A1 (en) 1992-07-05
DE69131624D1 (de) 1999-10-21
ATE184612T1 (de) 1999-10-15
US5494672A (en) 1996-02-27
EP0567470B1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
Isogai et al. Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae
DE69131624T2 (de) Peptidzusammensetzung aus pseudomonas und methode diese herzustellen
Matsuda et al. Dissociation of tetanus neurotoxin into two polypeptide fragments
AU1974992A (en) Pseudomonas exoenzyme s peptide composition and method
Yamamoto et al. Application of monoclonal antibodies to the isolation and characterization of a killer toxin secreted by Hansenula mrakii
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
HK1012841A1 (en) Pharmaceutical composition for the treatment or prevention of amalignant tumor
ATE168131T1 (de) T-cadherin-bindungsmolekül
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
GB9108652D0 (en) Immunoreactive compounds
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
ATE235916T1 (de) Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern
KR910004209A (ko) 에스케리키아 콜리 왁진
Kreft et al. Production, purification and characterization of hemolysins from Listeria ivanovii and Listeria monocytogenes Sv4b
DK0494294T3 (da) Bakterielle stressproteiner
WO1998011229A3 (en) Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
KR960701096A (ko) 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION)
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
EP2261253A3 (de) Gegen Clostridium difficile gerichtete Antikörper
Schleifer et al. The Immunochemistry of Peptidoglycan: Separation and Characterization of Antibodies to the Glycan and to the Peptide Subunit
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
Kato et al. Isolation of the major basic nuclear protein and its localization on chromosomes of the dinoflagellate, Oxyrrhis marina
Ohmizu et al. Major proteins released by a protein-producing bacterium, Bacillus brevis 47, are derived from cell wall protein
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee